AMC Donor Committee Meeting Decisions

1
AMC Donor Committee Meeting Decisions May 2, 2007
2
Organization and Governance

• For July meeting GAVI/WB/Donors will each provide
  a draft document setting out their respective
  responsibilities at each phase
• Canada to update DC establishment phase TORs UK
  to draft DC implementation phase TORs
• GAVI to highlight role of Secretariat vs Board
• GAVI will provide
• a paper on other GAVI activities related to AMC
• a glossary of defined terms
• GAVI will set up a password protected website to
  share documents
• Conference calls will be scheduled every 3 weeks
  (and as needed) with the whole group
• Next Donor Committee meeting July 6 in UK

3
IAC

• IAC nomination process will be extended
• Run another Economist ad, and in other relevant
  industry journals as time permits ensure
  consistency with website ad
• Revise ad slightly - Allow self-nomination
• GAVI will come back with recommendations on other
  journals and new extension date, by Fri May 11
• Donors/GAVI/WB to use networks to disseminate ad
• GAVI secretariat to send letters to current
  applicants indicating they dont need to apply
  again

4
IAC Cont.

• Donors will formally delegate the selection of
  the IAC to the Selection Panel, to be made up of
  reps from WB, GAVI and WHO
• Canada will draft a letter to WB/GAVI/WHO on
  behalf of the donors giving the Selection Panel
  the authority to make the final decision on the
  IAC
• Relevant documents will be amended to take into
  account the new role of the Selection Panel (i.e.
  including role previously proposed for GAVI
  Board)

5
DAC ODA Treatment of AMC

• Norway will send an email to donors stating
  position that AMC should be treated as a
  public-private partnership
• This position will be stated by the various
  donors at the next DAC WG on statistics meeting
  in mid-June

6
Budget

• At next weeks GAVI Board meeting
• GAVI to propose that it cover the serotype study
  costs, given issues raised by donors
• Norway, UK and Gates (GAVI Board members) to
  coordinate support for a proposal for GAVI to
  cover all AMC start-up costs, up to ceiling
• Admin costs not covered by GAVI are to be shared
  among donors in proportion to the amount of total
  donor commitment

7
Expert Group

• Donors to send any additional comments on Expert
  Group TORs by May 9 GAVI to send revision by May
  11
• Balance of developing country and gender
  expertise on group to be revisited by GAVI
• GAVI to clarify gaps in membership and ask donors
  to submit any additional names

8
Industry Consultation

• Strategy must be explicit that the industry
  consultation is not a negotiation
• Donors to send any additional comments on
  Industry Consultation strategy by May 9 GAVI to
  send revision by May 11
• consultation to include issue of currencies used
  in AMC price
• Italy will send a letter to pharma companies and
  relevant industry associations from Italian G7
  deputy
• The scope and team for the industry consultation
  was agreed in principle

9
Monitoring and Evaluation

• Monitoring and evaluation strategy agreed in
  principle, subject to revisions discussed in
  meeting
• Sub-group to begin their evaluability study
  DFID/CIDA plan to absorb 200K costs internally
• GAVI to add 100K costs to start-up proposal for
  GAVI Board, to cover additional consultant
  services that might be needed to finalize ME
  Framework after completion of evaluability study

10
Outreach

• UK and Communications sub-group to further
  elaborate rationale for outreach, including
  option for meeting back-to-back with next DC
  meeting, to be sent by May 11

11
Financing

• Donors to come to July meeting with clarity on
  (i) profile (ii) grant instrument of their
  payments
• WB to do note (versions for DC and for internal
  Board) that addresses bundling issue
• WB/donors to reflect on need for corporate
  finance advice